FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 3043145 · Received April 9, 2013

Report

Report Number
2124215-2013-03653
Event Type
Injury
Date Received
April 9, 2013
Date of Event
January 17, 2013
Report Date
March 28, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. VISUAL INSPECTION NOTED ALL SEAL PLUGS WERE INTACT AND ALL SETSCREWS MOVED FREELY. PIN GAUGE TESTING, DESIGNED TO VERIFY PROPER PORT DIMENSIONS, WAS COMPLETED. EACH PORT MEASURED AS EXPECTED. VISUAL INSPECTION OF THE HEADER PORT NOTED THE LOCATION OF THE LEAD SEAL RING MARKS INDICATED THE LEAD HAD NOT BEEN FULLY INSERTED WITHIN THE PORT. THIS WAS LIKELY THE CAUSE OF THE OUT OF RANGE PACING IMPEDANCES AND NOISE ON THE RV LEAD.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND IMPLANTABLE DEFIBRILLATION LEAD EXHIBITED PACING IMPEDANCE MEASUREMENTS GREATER THAN 2,000 OHMS. ADDITIONALLY, NOISE WAS OBSERVED ON THE RATE/SENSE CHANNEL. THE HIGH PACING IMPEDANCE MEASUREMENTS AND NOISE COULD NOT BE RECREATED IN CLINIC. AN INVASIVE PROCEDURE WAS PERFORMED. THE DEVICE WAS SUCCESSFULLY EXPLANTED AND REPLACED. THE LEAD WAS SURGICALLY ABANDONED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
147713 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 88 YR Hospitalization| L| R E110| E161| H177| 0175| 5076| 0184